How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Regan Peng is an AI founder and former senior tech executive, focused on personal AI, ...
The average daily trading volume for Recursion Pharmaceuticals (RXRX) is 18,839,987. The opening price for Recursion Pharmaceuticals today was 4.18.
This is a set of tools for Minecraft accounts that you own. It turns Microsoft login cookies into Minecraft tokens. It can refresh those tokens, check that they work, look up Minecraft usernames, and ...
Combining both makes the tool robust against watermarks, logos, and compression — a watermark disrupts the global hash slightly but barely affects the hundreds of background keypoints that ORB matches ...
Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Dario Amodei, CEO and co-founder of Anthropic ...
Anthropic and OpenAI researchers raised fresh concerns about recursive self-improvement, the process by which AI helps improve the development of models. Both OpenAI and Anthropic have in recent ...
“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...
AI CTO and systems builder. CTO of Archdesk; founder of Lextron.ai, Inclify and Rejsomat. I write on enterprise AI, agents and Joule Wars. RSI AI refers to artificial intelligence capable of recursive ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Recursion Pharmaceuticals reported 5 insider transactions totaling $528,153.30. Activity split between 3 Tax Payments worth $351,830.92 and 2 Sales worth $176,322.38. Ben R Taylor and Najat Khan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results